Chris Ryan | Authors


CAR T Cells Shown Effective Without Increased Risk of CRS or ICANS in CNS-Involved LBCL

April 25, 2022

Looking at 4 CAR T-cell agents for the treatment of large B-cell lymphoma, a systematic review and analysis showed that these therapies do not appear to increase the risk of cytokine release syndrome or immune effector cell–associated neurotoxicity syndrome.